Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2000;9(2):77–84. doi: 10.1080/096293500411532

The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.

K Asano 1, T Mizutani 1, T Shimane 1, M Hisano 1, T Hisamitsu 1, H Suzaki 1
PMCID: PMC1781752  PMID: 10958380

Abstract

The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (+/-)-[2-[4-(3-ethoxy-2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized by intraperitoneal injection of dinitrophenylated-keyhole limpet hemocyanin (DNP-KLH) mixed with A1(OH)3 (DNP-KLH). IPD-1151T was administered orally once a day for either 5 or 14 days in doses of 10, 30 or 100 mg/kg. Bronchoconstriction was measured 24h after the final drug administration. IPD-1151T inhibited both antigen- and MCh-mediated bronchoconstriction in actively sensitized mice. The inhibition induced was closely related to the dose and frequency of oral administration of the agent. We also examined the effect of IPD-1151T on IgE production in response to DNP-KLH immunization. IPD-1151T inhibited dose-dependently both total and specific IgE concentrations in serum prepared from mice 15 days after immunization. These results strongly indicate that IPD-1151T inhibits IgE production in vivo and results in attenuating effect on bronchoconstriction.

Full Text

The Full Text of this article is available as a PDF (254.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. A new approach to the treatment of asthma. N Engl J Med. 1989 Nov 30;321(22):1517–1527. doi: 10.1056/NEJM198911303212206. [DOI] [PubMed] [Google Scholar]
  2. Behrens B. L., Clark R. A., Marsh W., Larsen G. L. Modulation of the late asthmatic response by antigen-specific immunoglobulin G in an animal model. Am Rev Respir Dis. 1984 Dec;130(6):1134–1139. doi: 10.1164/arrd.1984.130.6.1134. [DOI] [PubMed] [Google Scholar]
  3. Bethel R. A., Curtis S. P., Lien D. C., Irvin C. G., Worthen G. S., Leff A. R., Henson P. M. Effect of PAF on parasympathetic contraction of canine airways. J Appl Physiol (1985) 1989 Jun;66(6):2629–2634. doi: 10.1152/jappl.1989.66.6.2629. [DOI] [PubMed] [Google Scholar]
  4. Burden D. T., Parkes M. W., Gardiner D. G. Effect of beta-adrenoceptive blocking agents on the response to bronchoconstrictor drugs in the guinea-pig air overflow preparation. Appendix describing a new modification of the air overflow method. Br J Pharmacol. 1971 Jan;41(1):122–131. doi: 10.1111/j.1476-5381.1971.tb09942.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dobashi K., Iizuka K., Houjou S., Sakai H., Watanabe K., Mori M., Nakazawa T. Effect of cetirizine on antigen-induced tracheal contraction of passively sensitized guinea pigs. Ann Allergy Asthma Immunol. 1996 Oct;77(4):310–318. doi: 10.1016/S1081-1206(10)63326-1. [DOI] [PubMed] [Google Scholar]
  6. Górski P., Kołacińska B., Wittczak T. Analysis of the clinical state of patients with occupational asthma following cessation of exposure to allergens. Occup Med (Lond) 1999 Jul;49(5):285–289. doi: 10.1093/occmed/49.5.285. [DOI] [PubMed] [Google Scholar]
  7. Hargreave F. E., Ryan G., Thomson N. C., O'Byrne P. M., Latimer K., Juniper E. F., Dolovich J. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 1981 Nov;68(5):347–355. doi: 10.1016/0091-6749(81)90132-9. [DOI] [PubMed] [Google Scholar]
  8. Iijima H., Tamura G., Hsiue T. R., Liu Y., Taniguchi H., Shirato K. Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. Am J Respir Crit Care Med. 1999 Jul;160(1):331–335. doi: 10.1164/ajrccm.160.1.9809059. [DOI] [PubMed] [Google Scholar]
  9. Juniper E. F., Frith P. A., Hargreave F. E. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax. 1981 Aug;36(8):575–579. doi: 10.1136/thx.36.8.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kimata H. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate. Ann Allergy Asthma Immunol. 1999 Mar;82(3):293–295. doi: 10.1016/S1081-1206(10)62611-7. [DOI] [PubMed] [Google Scholar]
  11. Koda A., Yanagihara Y., Matsuura N. IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Agents Actions Suppl. 1991;34:369–378. [PubMed] [Google Scholar]
  12. Konno S., Adachi M., Asano K., Gonogami Y., Ikeda K., Okamoto K., Takahashi T. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes. Eur J Pharmacol. 1994 Jun 23;259(1):15–20. doi: 10.1016/0014-2999(94)90151-1. [DOI] [PubMed] [Google Scholar]
  13. Konno S., Asano K., Kurokawa M., Ikeda K., Okamoto K., Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol. 1994 Nov;105(3):308–316. doi: 10.1159/000236773. [DOI] [PubMed] [Google Scholar]
  14. Larsen G. L., Renz H., Loader J. E., Bradley K. L., Gelfand E. W. Airway response to electrical field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes. J Clin Invest. 1992 Mar;89(3):747–752. doi: 10.1172/JCI115651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee W. Y., Sehon A. H. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates. J Immunol. 1976 Jun;116(6):1711–1718. [PubMed] [Google Scholar]
  16. MacDonald S. M., Lichtenstein L. M., Proud D., Plaut M., Naclerio R. M., MacGlashan D. W., Kagey-Sobotka A. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15;139(2):506–512. [PubMed] [Google Scholar]
  17. MacGlashan D. W., Jr, Peters S. P., Warner J., Lichtenstein L. M. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol. 1986 Mar 15;136(6):2231–2239. [PubMed] [Google Scholar]
  18. Marsh W. R., Irvin C. G., Murphy K. R., Behrens B. L., Larsen G. L. Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis. 1985 Jun;131(6):875–879. doi: 10.1164/arrd.1985.131.6.875. [DOI] [PubMed] [Google Scholar]
  19. Martin T. R., Gerard N. P., Galli S. J., Drazen J. M. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) 1988 Jun;64(6):2318–2323. doi: 10.1152/jappl.1988.64.6.2318. [DOI] [PubMed] [Google Scholar]
  20. Matsuura N., Mori H., Nagai H., Koda A. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions]. Nihon Yakurigaku Zasshi. 1992 Dec;100(6):495–501. doi: 10.1254/fpj.100.495. [DOI] [PubMed] [Google Scholar]
  21. Matsuura N., Mori H., Nagai H., Koda A. [Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice]. Nihon Yakurigaku Zasshi. 1992 Dec;100(6):485–493. doi: 10.1254/fpj.100.485. [DOI] [PubMed] [Google Scholar]
  22. Murphy K. R., Wilson M. C., Irvin C. G., Glezen L. S., Marsh W. R., Haslett C., Henson P. M., Larsen G. L. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis. 1986 Jul;134(1):62–68. doi: 10.1164/arrd.1986.134.1.62. [DOI] [PubMed] [Google Scholar]
  23. Murray J. J., Tonnel A. B., Brash A. R., Roberts L. J., 2nd, Gosset P., Workman R., Capron A., Oates J. A. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med. 1986 Sep 25;315(13):800–804. doi: 10.1056/NEJM198609253151304. [DOI] [PubMed] [Google Scholar]
  24. Oda N., Minoguchi K., Yokoe T., Hashimoto T., Wada K., Miyamoto M., Tanaka A., Kohno Y., Adachi M. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Life Sci. 1999;65(8):763–770. doi: 10.1016/s0024-3205(99)00303-3. [DOI] [PubMed] [Google Scholar]
  25. Ormstad H., Gaarder P. I., Johansen B. V., Løvik M. Airborne house dust elicits a local lymph node reaction and has an adjuvant effect on specific IgE production in the mouse. Toxicology. 1998 Aug 21;129(2-3):227–236. doi: 10.1016/s0300-483x(98)00079-1. [DOI] [PubMed] [Google Scholar]
  26. Ra C., Kuromitsu S., Hirose T., Yasuda S., Furuichi K., Okumura K. Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction. Int Immunol. 1993 Jan;5(1):47–54. doi: 10.1093/intimm/5.1.47. [DOI] [PubMed] [Google Scholar]
  27. Rabe K. F., Watson N., Dent G., Morton B. E., Wagner K., Magnussen H., Heusser C. H. Inhibition of human airway sensitization by a novel monoclonal anti-IgE antibody, 17-9. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1429–1435. doi: 10.1164/ajrccm.157.5.9708127. [DOI] [PubMed] [Google Scholar]
  28. Renz H., Smith H. R., Henson J. E., Ray B. S., Irvin C. G., Gelfand E. W. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol. 1992 Jun;89(6):1127–1138. doi: 10.1016/0091-6749(92)90296-e. [DOI] [PubMed] [Google Scholar]
  29. Ring J., Bieber T., Vieluf D., Kunz B., Przybilla B. Atopic eczema, Langerhans cells and allergy. Int Arch Allergy Appl Immunol. 1991;94(1-4):194–201. doi: 10.1159/000235361. [DOI] [PubMed] [Google Scholar]
  30. Tanaka D. T., Grunstein M. M. Effect of substance P on neurally mediated contraction of rabbit airway smooth muscle. J Appl Physiol (1985) 1986 Feb;60(2):458–463. doi: 10.1152/jappl.1986.60.2.458. [DOI] [PubMed] [Google Scholar]
  31. Tsukagoshi H., Nagashima M., Horie T., Oyama T., Yoshii A., Sato T., Iizuka K., Dobashi K., Mori M. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T). Intern Med. 1998 Dec;37(12):1064–1067. doi: 10.2169/internalmedicine.37.1064. [DOI] [PubMed] [Google Scholar]
  32. Tung R., Lichtenstein L. M. In vitro histamine release from basophils of asthmatic and atopic individuals in D2O. J Immunol. 1982 May;128(5):2067–2072. [PubMed] [Google Scholar]
  33. Tunon de Lara J. M., Okayama Y., Savineau J. P., Marthan R. IgE-induced passive sensitization of human isolated bronchi and lung mast cells. Eur Respir J. 1995 Nov;8(11):1861–1865. doi: 10.1183/09031936.95.08111861. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES